市場調査レポート
商品コード
1372526

ビタミンK2市場規模・動向、世界・地域シェア、動向、成長機会分析レポート、対象範囲:製品別、剤形別、供給源別、用途別、地域別

Vitamin K2 Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product, Dosage Forms, Source, Application, and Geography

出版日: | 発行: The Insight Partners | ページ情報: 英文 198 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ビタミンK2市場規模・動向、世界・地域シェア、動向、成長機会分析レポート、対象範囲:製品別、剤形別、供給源別、用途別、地域別
出版日: 2023年10月11日
発行: The Insight Partners
ページ情報: 英文 198 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ビタミンK2の市場規模は、2022年の1億4,400万米ドルから2030年には11億6,000万米ドルに達すると予測され、2022年から2030年までのCAGRは29.7%と推計されます。

ビタミンK2市場の成長は、CVDの有病率の増加と成人および新生児における骨粗鬆症の症例の増加に起因しています。しかし、ビタミンK2の利点に関する認知度が低いことが市場成長の妨げとなっています。

CVD有病率の増加がビタミンK2市場の成長を促進

心血管疾患(CVD)は世界的に重要な健康問題であり続けており、その有病率は近年着実に増加しています。この増加は、糖尿病、高コレステロール血症、高血圧などの危険因子の有病率の増加とともに、高齢化、座りがちなライフスタイル、食生活の乱れなどが原因となっています。世界保健機関(WHO)によると、CVDは死亡原因の第一位であり、世界全体で毎年1,790万人が死亡しています。また、欧州環境庁によれば、毎年600万人以上がCVDと診断され、170万人以上がCVDで死亡しています。

研究者たちは、CVDと闘うための様々な予防的・治療的アプローチを模索しています。ビタミンK2(メナキノン)はビタミンKの一種であり、心血管系の健康に役立つ可能性があります。ビタミンK2が心血管系の健康に影響を及ぼす重要なメカニズムは、カルシウム代謝を調節する役割です。カルシウム沈着が動脈壁に蓄積する過程である動脈石灰化は、CVDの主要な根本原因であるアテローム性動脈硬化症の発症に寄与します。ビタミンK2は、カルシウム沈着を制御するのに役立つタンパク質を活性化することによって動脈石灰化を抑制し、アテローム性動脈硬化症および関連する心血管障害のリスクを低下させるという重要な役割を果たすことが判明しています。

いくつかの観察研究では、ビタミンK2の摂取とCVD転帰との関連性が検討されています。これらの研究は明確な因果関係を立証することはできないが、興味深い知見を提供しています。Journal of Nutrition誌による研究では、ビタミンK2の摂取量が多いほど冠動脈性心疾患の死亡リスクが低いことが明らかにされました。さらに、ビタミンK2は、生活習慣の改善と並んで、補助的な治療法あるいは予防法として考慮されるべきです。このような生活習慣の改善には、果物、全粒穀物、野菜、赤身のタンパク質を多く含むバランスのとれた食事を摂ること、健康的な体重を維持すること、定期的な運動を行うこと、血圧やコレステロール値を管理すること、喫煙習慣をやめることなどが含まれます。このように、CVDの有病率の増加がビタミンK2市場を牽引しています。

ビタミンK2市場セグメント別概要

ビタミンK2市場は、製品、剤形、供給源、用途、地域によって区分されます。

製品別では、ビタミンK2市場はMK-4、MK-7、配合剤に区分されます。2022年には、MK-7セグメントが最大の市場シェアを占め、2022~2030年に最も速いCAGRを記録すると推定されます。メナキノン-7(MK-7)は、複数の身体機能に役立つ高度な脂溶性ビタミンK2です。MK-7の形のビタミンK2だけが、1日1回の摂取で骨と歯を24時間保護することが証明されています。MK-7は肝臓組織だけでなく、骨、動脈、軟部組織にも存在するため、体内での半減期が他のビタミンK2よりもはるかに長く、血液中に最も長く留まります。そのため、MK-7サプリメントは1日1回のみ摂取する必要があります。MenaQ7によると、1日45mcgのMK-7はカルボキシル化を増加させ、骨の健康のためのオステオカルシンや心臓の健康のためのマトリックスGLAタンパク質(MGP)などのビタミンK依存性タンパク質を活性化することができます。

ビタミンK2市場は剤形によって、カプセル・錠剤、粉末、オイルに区分されます。2022年には粉末セグメントが最大の市場シェアを占め、2022~2030年には最も速いCAGRを記録すると推定されます。ビタミン粉末は水やその他の液体で素早く崩壊します。水と一緒に摂取する場合、ビタミンK2製品は粉末の方が吸収が早く、カプセルや錠剤よりも効果的です。ビタミンK2パウダーで高カルシウム値を抑制。ビタミンK2はカルシウムの吸収を抑え、腎臓結石や骨粗鬆症の発症リスクを低下させます。ワルファリンのような血液をサラサラにする薬(抗凝固薬)は出血を引き起こしますが、ビタミンK2はそれを止めたり遅らせたりします。従って、このような要因から、粉末セグメントは予測期間中に大きく成長すると予想されます。

供給源に基づいて、ビタミンK2市場は天然と合成に二分されます。2022年には、天然セグメントがより大きな市場シェアを占め、2022~2030年にはより速いCAGRを記録すると推定されます。濃い葉野菜に含まれる天然ビタミンK2は、代謝と血液凝固に不可欠です。ビタミンK2(メナキノン)は、内臓肉や発酵食品に少量含まれています。腸内細菌もビタミンK2を産生します。発酵食品は良いビタミンK2供給源です。内臓肉や高脂肪乳製品は脂溶性であるため、かなりの量のビタミンK2を含んでいます。人間の腸内細菌も少量のK2を産生します。

ビタミンK2市場は、用途別に医薬品、栄養補助食品、食品、その他に区分されます。2022年には医薬品分野が最大の市場シェアを占め、2022~2030年には栄養補助食品・食品分野が最も速いCAGRを記録すると推定されます。栄養補助食品・食品分野は、様々な栄養不足に対処するための栄養補助食品に対する顧客の需要が高いことから、急成長が見込まれています。ビタミンK2は栄養補助食品として食品に添加され、栄養価を高める。最終用途の方向性に応じて、ビタミンK2は食品、健康・栄養補助食品、機能性食品で消費されます。また、"納豆"と呼ばれる日本の伝統料理にも含まれています。納豆は、プロピオン酸菌や乳酸菌など、さまざまな種類の菌を使って発酵させた大豆からできています。

ビタミンK2市場地理的概要

地域別に見ると、ビタミンK2市場は5つの主要地域に区分される:北米、欧州、アジア太平洋、中南米、中東・アフリカです。2022年には、北米がvK2市場で最大のシェアを占めています。アジア太平洋は、2022~2030年の間、世界のvK2市場で最も高いCAGRを記録すると予想されています。

アジア太平洋のビタミンK2市場は、中国、日本、インド、韓国、オーストラリア、その他のアジア太平洋に区分されます。この地域のビタミンK2市場の成長は、企業間の共同研究、心血管疾患(CVD)の有病率の上昇、高齢化人口の増加によって広く牽引されています。2022年4月に発表された調査論文「中国における心血管疾患死亡率と潜在的危険因子」は、心血管疾患(CVD)が中国における深刻な医療負担の一つであることに言及しています。中国では、2億9,000万人が冠動脈性心疾患(1,100万人)、心臓疾患(1,300万人)、心不全(450万人)、肺性心疾患(500万人)、リウマチ性心疾患(250万人)、先天性心疾患(200万人)、高血圧(2億4,500万人)に苦しんでいます。また、同記事によれば、中国は世界全体のCVDに関連する死亡率の40%を占めています。ビタミンK2は、カルシウムのホメオスタシスを調整することによって、心臓血管の健康に重要な役割を果たしています。ビタミンK2サプリメントは、動脈硬化および全身の石灰化を修正することによって心血管系の転帰を改善することと強く相関しています。手ごろな価格と食品医薬品局(FDA)が証明した安全性に支えられ、ビタミンK2サプリメントは心血管系の転帰を改善するための実行可能で有利な選択肢です。したがって、中国におけるCVDの負担と有病率の増加は、ビタミンK2サプリメントの需要を増加させ、市場の成長を後押しすると予想されます。

市場競争力を維持するため、複数の市場参入企業が有機的戦略を採用しています。例えば、2022年6月、Balchem CorporationはKappa Bioscience ASの完全買収を発表しました。この買収により、Balchem社はKappa Bioscience AS社の特殊ビタミンK2を追加し、製品ポートフォリオを拡大しました。

2022年10月、PLT Health Solutions, Inc.は、non-GMO Project社から同社のメナトについてnon-GMO認証の提供を受けたと発表しました。2022年3月、DSMは食用油製造会社J-オイルミルズ(東京)が製造するメナットを米国で発売しました。

2023年5月、DSMはファルメニッヒと合併し、重要な栄養素、フレーバー、香りを再発明し、製造し、組み合わせるための強固なプラットフォームを構築しました。DSMとフィルメニッヒは、栄養、健康、美容の分野で競争力と成長機会を持つ新ブランド「dsm-firmenich」を設立すると発表しました。

2023年4月、DSMはアデア・ファーマ・ソリューションズとの間で、アデア・バイオームを3億120万米ドル(2億7,500万ユーロ)で買収する交渉を発表しました。この買収により、DSMはヒトの健康と動物用栄養製品の提供を拡大することができます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 ビタミンK2市場情勢

  • イントロダクション
  • PEST分析
    • 北米PEST分析

第5章 ビタミンK2市場:主要産業力学

  • 主な市場促進要因
    • CVDの有病率の増加
    • 成人および新生児における骨粗鬆症の症例増加
  • 市場抑制要因
    • ビタミンK2の効能に関する認知度の低下
  • 市場機会
    • 流通チャネルの拡大
  • 今後の動向
    • 法規制と規格
  • 影響分析

第6章 ビタミンK2市場:世界市場分析

  • ビタミンK2市場の収益、2022年~2030年

第7章 ビタミンK2の世界市場:2030年までの収益と予測:製品別

  • イントロダクション
  • ビタミンK2市場収入シェア、製品別、2022年・2030年(%)
  • MK-4
  • MK-7
  • 配合剤

第8章 ビタミンK2の世界市場:2030年までの収益と予測:剤形別

  • イントロダクション
  • ビタミンK2市場収入シェア、剤形別、2022年・2030年(%)
  • カプセルと錠剤
  • 粉末
  • オイル

第9章 ビタミンK2の世界市場:2030年までの収益と予測:供給源別

  • イントロダクション
  • ビタミンK2市場収入シェア、供給源別、2022年・2030年(%)
  • 天然
  • 合成

第10章 ビタミンK2の世界市場:2030年までの収益と予測:用途別

  • イントロダクション
  • ビタミンK2市場収入シェア、用途別、2022年・2030年(%)
  • 医薬品
  • 栄養補助食品と食品
  • その他

第11章 ビタミンK2市場-地域別分析

  • 北米
    • メキシコ
  • 欧州
    • その他の欧州
  • アジア太平洋
    • その他のアジア太平洋
  • 中東・アフリカ
    • その他の中東およびアフリカ
  • 中南米
    • その他の中南米

第12章 ビタミンK2市場の業界情勢

  • イントロダクション
  • ビタミンK2市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第13章 企業プロファイル

  • Lonza Group AG
  • International Flavors & Fragrances Inc
  • Balchem Corp
  • BASF SE
  • Lesaffre et Cie SA
  • Seebio Biotech(Shanghai)Co Ltd
  • Koninklijke DSM NV
  • Novozymes AS
  • Glanbia Plc
  • Anderson Global Group LLC

第14章 付録

図表

List Of Tables

  • Table 1. Vitamin K2 Market Segmentation
  • Table 2. North America Vitamin K2 Market, by Product- Revenue and Forecast to 2030 (US$ Million)
  • Table 3. North America Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America Vitamin K2 Market, by Source - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. North America Vitamin K2 Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. US Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. US Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 8. US Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 9. US Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Canada Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Canada Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Canada Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Canada Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Mexico Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Mexico Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Mexico Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Mexico Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 19. Europe Vitamin K2 Market Revenue And Forecast To 2030 (US$ Mn) - Surgery
  • Table 20. Europe Vitamin K2 Market Revenue And Forecast To 2030 (US$ Mn) - Source
  • Table 21. Europe Vitamin K2 Market Revenue And Forecast To 2030 (US$ Mn) - Application
  • Table 22. Germany Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 23. Germany Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
  • Table 24. Germany Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 25. Germany Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 26. UK Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 27. UK Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
  • Table 28. UK Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 29. UK Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 30. France Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 31. France Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
  • Table 32. France Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 33. France Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 34. Italy Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 35. Italy Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
  • Table 36. Italy Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 37. Italy Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 38. Spain Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 39. Spain Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
  • Table 40. Spain Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 41. Spain Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 42. Rest of Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 43. Rest of Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Surgery
  • Table 44. Rest of Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 45. Rest of Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 46. Asia Pacific Vitamin K2 Market, by Product- Revenue and Forecast to 2030 (US$ Million)
  • Table 47. Asia Pacific Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 48. Asia Pacific Vitamin K2 Market, by Source - Revenue and Forecast to 2030 (US$ Million)
  • Table 49. Asia Pacific Vitamin K2 Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 50. China Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 51. China Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 52. China Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 53. China Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 54. Japan Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 55. Japan Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 56. Japan Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 57. Japan Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 58. India Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 59. India Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 60. India Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 61. India Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 62. Australia Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 63. Australia Pacific Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 64. Australia Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 65. Australia Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 66. South Korea Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 67. South Korea Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 68. South Korea Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 69. South Korea Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 70. Rest of Asia Pacific Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 71. Rest of Asia Pacific Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 72. Rest of Asia Pacific Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 73. Rest of Asia Pacific Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 74. Middle East and Africa Vitamin K2 Market, by Product- Revenue and Forecast to 2030 (US$ Million)
  • Table 75. Middle East and Africa Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 76. Middle East and Africa Vitamin K2 Market, by Source - Revenue and Forecast to 2030 (US$ Million)
  • Table 77. Middle East and Africa Vitamin K2 Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 78. South Africa Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 79. South Africa Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 80. South Africa Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 81. South Africa Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 82. Saudi Arabia Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 83. Saudi Arabia Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 84. Saudi Arabia Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 85. Saudi Arabia Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 86. U.A.E Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 87. U.A.E Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 88. U.A.E Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 89. U.A.E Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 90. Rest of Middle East and Africa Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 91. Rest of Middle East and Africa Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 92. Rest of Middle East and Africa Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 93. Rest of Middle East and Africa Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 94. South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 95. South & Central America Vitamin K2 Market Revenue and Forecast To 2030 (US$ Mn) - Surgery
  • Table 96. South & Central America Vitamin K2 Market Revenue and Forecast To 2030 (US$ Mn) - Source
  • Table 97. South & Central America Vitamin K2 Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 98. Brazil Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 99. Brazil Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - Surgery
  • Table 100. Brazil Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 101. Brazil Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 102. Argentina Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 103. Argentina Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - Surgery
  • Table 104. Argentina Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 105. Argentina Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 106. Rest of South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 107. Rest of South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - Surgery
  • Table 108. Rest of South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 109. Rest of South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 110. Recent Organic Growth Strategies in Vitamin K2 Market
  • Table 111. Recent Inorganic Growth Strategies in the Vitamin K2 Market
  • Table 112. Glossary of Terms, Vitamin K2 Market

List Of Figures

  • Figure 1. Vitamin K2 Market Segmentation, By Geography
  • Figure 2. North America - PEST Analysis
  • Figure 3. Vitamin K2 Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Vitamin K2 Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Vitamin K2 Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 7. MK-4: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. MK-7: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Combination Drugs: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Vitamin K2 Market Revenue Share, by Dosage Form 2022 & 2030 (%)
  • Figure 11. Capsules and Tablets: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Powder: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Oil: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Vitamin K2 Market Revenue Share, by Source 2022 & 2030 (%)
  • Figure 15. Natural: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Synthetic: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Vitamin K2 Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 18. Pharmaceuticals: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Nutraceuticals and Food: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Others: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. North America: Vitamin K2 Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 22. North America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. North America: North America, by Country, 2022 & 2030 (%)
  • Figure 24. US: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Canada: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Mexico: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Europe Vitamin K2 Market, By Geography, 2022 ($Mn)
  • Figure 28. Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Europe Vitamin K2 Market, By Key Countries, 2022 And 2030 (%)
  • Figure 30. AS is the most common valvular heart disease, with a dismal prognosis when untreated. Recommended therapy is SAVR or TAVR.
  • Figure 31. Germany Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 32. UK Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 33. France Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 34. Italy Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 35. Spain Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 36. Rest of Europe Vitamin K2 Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 37. Asia Pacific: Vitamin K2 Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 38. Asia Pacific Vitamin K2 Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 39. Asia Pacific: Vitamin K2 Market, by Country, 2022 & 2030 (%)
  • Figure 40. China: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 41. Japan: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 42. India: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 43. Australia: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 44. South Korea: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 45. Rest of Asia Pacific: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 46. Middle East and Africa: Vitamin K2 Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 47. Middle East and Africa Vitamin K2 Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 48. Middle East and Africa: Vitamin K2 Market, by Country, 2022 & 2030 (%)
  • Figure 49. South Africa: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 50. Saudi Arabia: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 51. U.A.E: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 52. Rest of Middle East and Africa: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 53. Vitamin K2 Market, By Geography, 2022 ($Mn)
  • Figure 54. South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 55. South & Central America Vitamin K2 Market, By Key Countries, 2022 and 2030 (%)
  • Figure 56. Brazil Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 57. Argentina Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 58. Rest of South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 59. Growth Strategies in Vitamin K2 Market
目次
Product Code: TIPRE00028583

The vitamin K2 market size is projected to reach US$ 1.160 billions by 2030 from US$ 0.144 billions in 2022; the market is estimated to record a CAGR of 29.7% from 2022 to 2030.

The vitamin K2 market growth is attributed to increasing prevalence of CVD and growing cases of osteoporosis in adults and newborns. However, limited awareness regarding benefits of vitamin K2 is hindering the market growth.

Increasing Prevalence of CVD Propels Vitamin K2 Market Growth

Cardiovascular disease (CVD) continues to be a significant global health concern, with its prevalence steadily increasing in recent years. This rise is due to the aging population, sedentary lifestyles, and poor dietary choices, along with the growing prevalence of risk factors, including diabetes, hypercholesterolemia, and hypertension. According to the World Health Organization, CVD is a leading cause of death, registering ~17.9 million deaths every year globally. Additionally, as per the European Environment Agency, every year, more than 6 million CVD are diagnosed, and over 1.7 million people die from CVD, representing 37% of all deaths in in the European Union in 2022, making it a leading cause of death.

Researchers are exploring various preventive and therapeutic approaches to combat CVD. One area of interest is the potential role of vitamin K2 in cardiovascular health. vitamin K2, or menaquinone, is a form of vitamin K linked to potential cardiovascular benefits. A critical mechanism by which vitamin K2 impacts cardiovascular health is its role in regulating calcium metabolism. Arterial calcification, the process of calcium deposits accumulating in the arterial walls, contributes to the development of atherosclerosis, a major underlying cause of CVD. vitamin K2 has been found to play a significant role in inhibiting arterial calcification by activating proteins that help regulate calcium deposition, thus reducing the risk of atherosclerosis and related cardiovascular disorders.

Several observational studies have examined the potential association between vitamin K2 intake and CVD outcomes. While these studies are unable to establish a definitive cause-and-effect relationship, they have provided interesting insights. A study by the Journal of Nutrition found that higher vitamin K2 intake was linked to a lower risk of coronary heart disease mortality. Further, vitamin K2 should be considered a potential adjunctive therapy or preventive measure alongside lifestyle changes. These modifications include adopting a balanced diet rich in fruits, whole grains, vegetables, and lean proteins; maintaining a healthy weight; engaging in regular physical activity; managing blood pressure and cholesterol levels; and stopping smoking habits. Thus, the increasing prevalence of CVD is driving the vitamin K2 market.

Vitamin K2 Market: Segmental Overview

The vitamin K2 market is segmented on the basis of product, dosage forms, source, application, and geography.

The vitamin K2 market, by product, is segmented into MK-4, MK-7, and combination drugs. In 2022, the MK-7 segment held the largest market share, and it is estimated to register the fastest CAGR during 2022-2030. Menaquinone-7 (MK-7) is an advanced, fat-soluble form of vitamin K2 that serves multiple bodily functions. Only vitamin K2 in the form of MK-7 has been proven to provide 24-hour protection to bones and teeth from a single daily dose. MK-7 has a much longer half-life in the body and stays in the blood the longest than other forms of vitamin K2, owing to its presence not only in liver tissues but also in bones, arteries, and soft tissues. Therefore, MK-7 supplementation must only be taken once daily. According to MenaQ7, 45 mcg of MK-7 per day can increase carboxylation and activate vitamin K-dependent proteins, such as osteocalcin for bone health and Matrix GLA Protein (MGP) for heart health.

Based on dosage forms, the vitamin K2 market is segmented into capsules & tablets, powder, and oils. In 2022, the powder segment held the largest market share, and it is estimated to register the fastest CAGR during 2022-2030. Vitamin powder disintegrates quickly in water and other liquids. When taken with water, vitamin K2 products get absorbed faster in powder form and are more effective than in capsule or tablet form. High calcium level is controlled with vitamin K2 powder. Vitamin K2 helps reduce calcium absorption and lower the risk of developing kidney stones or osteoporosis. Blood-thinning drugs (anticoagulants), such as warfarin, can cause bleeding, which vitamin K2 stops and slows down. Thus, owing to such factors, the powder segment is expected to grow considerably during the forecast period.

Based on source, the vitamin K2 market is bifurcated into natural and synthetic. In 2022, the natural segment held a larger market share and is estimated to register a faster CAGR during 2022-2030. Natural vitamin K2 found in dark leafy greens is essential for metabolism and blood clotting. Vitamin K2, or menaquinone, is present in small amounts in offal and fermented foods. Gut bacteria also produce vitamin K2. Fermented foods are good vitamin K2 sources. Offal and high-fat dairy products contain significant amounts of vitamin K2 because of their fat-soluble properties. Bacteria residing in the human gut also produce small amounts of K2.

Based on application, the vitamin K2 market is segmented into pharmaceuticals, nutraceuticals and food, and others. In 2022, the pharmaceuticals segment held the largest market share, and the nutraceuticals and food segment is estimated to register the fastest CAGR during 2022-2030. The nutraceuticals and food segment is expected to grow rapidly due to high customer demand for nutritional and dietary supplements to address various nutritional deficiencies. Vitamin K2 is added as a dietary supplement in food to increase its nutritional value. Depending on the end-use direction, vitamin K2 can be consumed in food, health and dietary supplements, and functional foods. It is also found in a traditional Japanese dish called "natto." Natto is composed of fermented soybeans using different types of bacteria, including propionic acid bacteria and lactic acid bacteria.

Vitamin K2 Market: Geographical Overview

Based on geography, the vitamin K2 market is segmented into five key regions: North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2022, North America accounted for the largest share of the vK2 market. Asia Pacific is expected to register the highest CAGR in the global vK2 market during 2022-2030.

The Asia Pacific vitamin K2 market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The growth of the vitamin K2 market in this region is widely driven by collaborations between companies, rising prevalence of cardiovascular disease (CVD), and an increasing aging population. A research article, "Cardiovascular Disease Mortality and Potential Risk Factor in China," published in April 2022, mentioned that cardiovascular disease (CVD) is one of the serious healthcare burdens in China. In China, 290 million people suffer from coronary heart disease (11 million), cardiac disorders (13 million), heart failure (4.5), pulmonary heart disease (5 million), rheumatic heart disease (2.5 million), congenital heart disease (2 million), and hypertension (245 million). The article also states that China accounts for 40% of the total mortality related to CVD globally. Vitamin K2 plays a vital role in cardiovascular health by regulating calcium homeostasis. Vitamin K2 supplements strongly correlate with enhanced cardiovascular outcomes by modifying arterial stiffness and systemic calcification. Supported by its affordability and Food and Drug Administration (FDA)-proven safety, vitamin K2 supplements are a viable and favorable option to enhance cardiovascular outcomes. Thus, the growing burden and prevalence of CVD among the population in China is expected to increase the demand for vitamin K2 supplements, thereby boosting the market growth.

Several market players are adopting organic strategies to stay competitive in the market. For instance, In June 2022, Balchem Corporation announced the complete acquisition of Kappa Bioscience AS. The acquisition has helped Balchem expand its product portfolio by adding Kappa Bioscience AS's specialty vitamin K2.

In October 2022, PLT Health Solutions, Inc. announced that non-GMO Project company offered it non-GMO verification for its menatto. In March 2022, the company introduced menatto in the US, which is manufactured by edible oils producer J-Oil Mills, Tokyo, Japan.

In May 2023, DSM merged into Firmenich to create a robust platform for reinventing, manufacturing, and combining vital nutrients, flavors, and fragrances. The announcement was made to create a new brand called dsm-firmenich, under which the companies will have a competitive edge and growth opportunities for nutrition, health, and beauty segments.

In April 2023, DSM announced negotiations with Adare Pharma Solutions to acquire its Adare Biome for US$ 301.2 million (€275 million). The acquisition will enable DSM to expand its human health and animal nutrition offerings.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the vitamin K2 market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global vitamin K2 market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global vitamin K2 market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution. 

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Vitamin K2 Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis

5. Vitamin K2 Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Prevalence of CVD
    • 5.1.2 Growing Cases of Osteoporosis Bone Deformation in Adults and Newborns
  • 5.2 Market Restraints
    • 5.2.1 Limited Awareness Regarding Benefits of Vitamin K2
  • 5.3 Market Opportunities
    • 5.3.1 Expansion of Distribution Channel
  • 5.4 Future Trends
    • 5.4.1 Regulatory Consideration and Standards
  • 5.5 Impact Analysis:

6. Vitamin K2 Market - Global Market Analysis

  • 6.1 Vitamin K2 Market Revenue (US$ Mn), 2022 - 2030

7. Global Vitamin K2 Market - Revenue and Forecast to 2030 - by Product.

  • 7.1 Overview
  • 7.2 Vitamin K2 Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 MK-4
    • 7.3.1 Overview
    • 7.3.2 MK-4: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 MK-7
    • 7.4.1 Overview
    • 7.4.2 MK-7: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Combination Drugs
    • 7.5.1 Overview
    • 7.5.2 Combination Drugs: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Vitamin K2 Market - Revenue and Forecast to 2030 - by Dosage Form.

  • 8.1 Overview
  • 8.2 Vitamin K2 Market Revenue Share, by Dosage Form, 2022 & 2030 (%)
  • 8.3 Capsules and Tablets
    • 8.3.1 Overview
    • 8.3.2 Capsules and Tablets: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Powder
    • 8.4.1 Overview
    • 8.4.2 Powder: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Oil
    • 8.5.1 Overview
    • 8.5.2 Oil: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Vitamin K2 Market - Revenue and Forecast to 2030 - by Source.

  • 9.1 Overview
  • 9.2 Vitamin K2 Market Revenue Share, by Source, 2022 & 2030 (%)
  • 9.3 Natural
    • 9.3.1 Overview
    • 9.3.2 Natural: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Synthetic
    • 9.4.1 Overview
    • 9.4.2 Synthetic: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

10. Global Vitamin K2 Market - Revenue and Forecast to 2030 - by Application.

  • 10.1 Overview
  • 10.2 Vitamin K2 Market Revenue Share, by Application, 2022 & 2030 (%)
  • 10.3 Pharmaceuticals
    • 10.3.1 Overview
    • 10.3.2 Pharmaceuticals: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Nutraceuticals and Food
    • 10.4.1 Overview
    • 10.4.2 Nutraceuticals and Food: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

11. Vitamin K2 Market - Geographical Analysis

  • 11.1 North America: Vitamin K2 Market
    • 11.1.1 Overview
    • 11.1.2 North America: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.1.3 North America: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
    • 11.1.4 North America: Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
    • 11.1.5 North America: Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
    • 11.1.6 North America: Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
    • 11.1.7 North America: North America, by Country, 2022 & 2030 (%)
      • 11.1.7.1 US: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.1.1 Overview
        • 11.1.7.1.2 US: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.1.3 US: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.1.7.1.4 US: Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.1.7.1.5 US: Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.1.7.1.6 US: Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
      • 11.1.7.2 Canada: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.2.1 Overview
        • 11.1.7.2.2 Canada: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.2.3 Canada: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.1.7.2.4 Canada: Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.1.7.2.5 Canada: Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.1.7.2.6 Canada: Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
      • 11.1.7.3 Mexico: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.3.1 Overview
        • 11.1.7.3.2 Mexico: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.3.3 Mexico: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.1.7.3.4 Mexico: Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.1.7.3.5 Mexico: Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.1.7.3.6 Mexico: Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
  • 11.2 Europe Vitamin K2 Market, Revenue and Forecast to 2030
    • 11.2.1 Overview
    • 11.2.2 Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.3 Europe Vitamin K2 Market, by Product
    • 11.2.4 Europe Vitamin K2 Market, by Dosage Form
    • 11.2.5 Europe Vitamin K2 Market, by Source
    • 11.2.6 Europe Vitamin K2 Market, by Application
    • 11.2.7 Europe Vitamin K2 Market by Country
      • 11.2.7.1 Germany
        • 11.2.7.1.1 Overview
        • 11.2.7.1.2 Germany Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.1.3 Germany Vitamin K2 Market, by Product
        • 11.2.7.1.4 Germany Vitamin K2 Market, by Dosage Form
        • 11.2.7.1.5 Germany Vitamin K2 Market, by Source
        • 11.2.7.1.6 Germany Vitamin K2 Market, by Application
      • 11.2.7.2 UK
        • 11.2.7.2.1 Overview
        • 11.2.7.2.2 UK Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.2.3 UK Vitamin K2 Market, by Product
        • 11.2.7.2.4 UK Vitamin K2 Market, by Dosage Form
        • 11.2.7.2.5 UK Vitamin K2 Market, by Source
        • 11.2.7.2.6 UK Vitamin K2 Market, by Application
      • 11.2.7.3 France
        • 11.2.7.3.1 Overview
        • 11.2.7.3.2 France Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.3.3 France Vitamin K2 Market, by Product
        • 11.2.7.3.4 France Vitamin K2 Market, by Dosage Form
        • 11.2.7.3.5 France Vitamin K2 Market, by Source
        • 11.2.7.3.6 France Vitamin K2 Market, by Application
      • 11.2.7.4 Italy
        • 11.2.7.4.1 Overview
        • 11.2.7.4.2 Italy Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.4.3 Italy Vitamin K2 Market, by Product
        • 11.2.7.4.4 Italy Vitamin K2 Market, by Dosage Form
        • 11.2.7.4.5 Italy Vitamin K2 Market, by Source
        • 11.2.7.4.6 Italy Vitamin K2 Market, by Application
      • 11.2.7.5 Spain
        • 11.2.7.5.1 Overview
        • 11.2.7.5.2 Spain Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.5.3 Spain Vitamin K2 Market, by Product
        • 11.2.7.5.4 Spain Vitamin K2 Market, by Dosage Form
        • 11.2.7.5.5 Spain Vitamin K2 Market, by Source
        • 11.2.7.5.6 Spain Vitamin K2 Market, by Application
      • 11.2.7.6 Rest of Europe
        • 11.2.7.6.1 Overview
        • 11.2.7.6.2 Rest of Europe Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.6.3 Rest of Europe Vitamin K2 Market, by Product
        • 11.2.7.6.4 Rest of Europe Vitamin K2 Market, by Dosage Form
        • 11.2.7.6.5 Rest of Europe Vitamin K2 Market, by Source
        • 11.2.7.6.6 Rest of Europe Vitamin K2 Market, by Application
  • 11.3 Asia Pacific: Vitamin K2 Market
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.3.3 Asia Pacific: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
    • 11.3.4 Asia Pacific: Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
    • 11.3.5 Asia Pacific: Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
    • 11.3.6 Asia Pacific: Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
    • 11.3.7 Asia Pacific: Vitamin K2 Market, by Country, 2022 & 2030 (%)
      • 11.3.7.1 China: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.1.1 Overview
        • 11.3.7.1.2 China: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.1.3 China: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.3.7.1.4 China: Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.3.7.1.5 China: Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.3.7.1.6 China: Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
      • 11.3.7.2 Japan: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.2.1 Overview
        • 11.3.7.2.2 Japan: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.2.3 Japan: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.3.7.2.4 Japan: Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.3.7.2.5 Japan: Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.3.7.2.6 Japan: Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
      • 11.3.7.3 India: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.3.1 Overview
        • 11.3.7.3.2 India: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.3.3 India: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.3.7.3.4 India: Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.3.7.3.5 India: Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.3.7.3.6 India: Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
      • 11.3.7.4 Australia: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.4.1 Overview
        • 11.3.7.4.2 Australia: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.4.3 Australia: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.3.7.4.4 Australia Pacific Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.3.7.4.5 Australia Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.3.7.4.6 Australia Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
      • 11.3.7.5 South Korea: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.5.1 Overview
        • 11.3.7.5.2 South Korea: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.5.3 South Korea: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.3.7.5.4 South Korea Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.3.7.5.5 South Korea Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.3.7.5.6 South Korea Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
      • 11.3.7.6 Rest of Asia Pacific: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.6.1 Overview
        • 11.3.7.6.2 Rest of Asia Pacific: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.6.3 Rest of Asia Pacific: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.3.7.6.4 Rest of Asia Pacific Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.3.7.6.5 Rest of Asia Pacific Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.3.7.6.6 Rest of Asia Pacific Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
  • 11.4 Middle East and Africa: Vitamin K2 Market
    • 11.4.1 Overview
    • 11.4.2 Middle East and Africa: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.4.3 Middle East and Africa: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
    • 11.4.4 Middle East and Africa: Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
    • 11.4.5 Middle East and Africa: Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
    • 11.4.6 Middle East and Africa: Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
    • 11.4.7 Middle East and Africa: Vitamin K2 Market, by Country, 2022 & 2030 (%)
      • 11.4.7.1 South Africa: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.1.1 Overview
        • 11.4.7.1.2 South Africa: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.1.3 South Africa: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.4.7.1.4 South Africa: Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.4.7.1.5 South Africa: Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.4.7.1.6 South Africa: Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
      • 11.4.7.2 Saudi Arabia: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.2.1 Overview
        • 11.4.7.2.2 Saudi Arabia: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.2.3 Saudi Arabia: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.4.7.2.4 Saudi Arabia: Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.4.7.2.5 Saudi Arabia: Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.4.7.2.6 Saudi Arabia: Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
      • 11.4.7.3 U.A.E: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.3.1 Overview
        • 11.4.7.3.2 U.A.E: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.3.3 U.A.E: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.4.7.3.4 U.A.E: Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.4.7.3.5 U.A.E: Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.4.7.3.6 U.A.E: Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
      • 11.4.7.4 Rest of Middle East and Africa: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.4.1 Overview
        • 11.4.7.4.2 Rest of Middle East and Africa: Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.4.3 Rest of Middle East and Africa: Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 11.4.7.4.4 Rest of Middle East and Africa Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 11.4.7.4.5 Rest of Middle East and Africa Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 11.4.7.4.6 Rest of Middle East and Africa Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
  • 11.5 South & Central America Vitamin K2 Market, Revenue and Forecast to 2030
    • 11.5.1 Overview
    • 11.5.2 South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.5.3 South & Central America Vitamin K2 Market, by Product
    • 11.5.4 South & Central America Vitamin K2 Market, by Dosage Form
    • 11.5.5 South & Central America Vitamin K2 Market, by Source
    • 11.5.6 South & Central America Vitamin K2 Market, by Application
    • 11.5.7 South & Central America Vitamin K2 Market by Country
      • 11.5.7.1 Brazil
        • 11.5.7.1.1 Overview
        • 11.5.7.1.2 Brazil Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.7.1.3 Brazil Vitamin K2 Market, by Product
        • 11.5.7.1.4 Brazil Vitamin K2 Market, by Dosage Form
        • 11.5.7.1.5 Brazil Vitamin K2 Market, by End-User
        • 11.5.7.1.6 Brazil Vitamin K2 Market, by Application
      • 11.5.7.2 Argentina
        • 11.5.7.2.1 Overview
        • 11.5.7.2.2 Argentina Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.7.2.3 Argentina Vitamin K2 Market, by Product
        • 11.5.7.2.4 Argentina Vitamin K2 Market, by Dosage Form
        • 11.5.7.2.5 Argentina Vitamin K2 Market, by End-User
        • 11.5.7.2.6 Argentina Vitamin K2 Market, by Application
      • 11.5.7.3 Rest of South & Central America
        • 11.5.7.3.1 Overview
        • 11.5.7.3.2 Rest of South & Central America Vitamin K2 Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.7.3.3 Rest of South & Central America Vitamin K2 Market, by Product
        • 11.5.7.3.4 Rest of South & Central America Vitamin K2 Market, by Dosage Form
        • 11.5.7.3.5 Rest of South & Central America Vitamin K2 Market, by End-User
        • 11.5.7.3.6 Rest of South & Central America Vitamin K2 Market, by Application

12. Vitamin K2 Market Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Vitamin K2 Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Lonza Group AG
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 International Flavors & Fragrances Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Balchem Corp
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 BASF SE
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Lesaffre et Cie SA
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Seebio Biotech (Shanghai) Co Ltd
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Koninklijke DSM NV
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Novozymes AS
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Glanbia Plc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Anderson Global Group LLC
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms